- Advertisement -
(Bloomberg) — A potential “magic mushroom” cure for depression could give stagnating psychedelic stocks a leg up if the results of a study expected before year end are encouraging.
Most Read from Bloomberg
Tuesday, June 16, 2026
The Australian Online News Network acknowledges the traditional custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.